Bottle of lies : (Record no. 38369)

000 -LEADER
fixed length control field 01745cam a22002058i 4500
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9789391165321
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng.
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
Item number EBA-B
100 1# - MAIN ENTRY--AUTHOR NAME
Personal name Eban, Katherine
Relator term author.
245 10 - TITLE STATEMENT
Title Bottle of lies :
Sub Title Ranbaxy and the dark side of Indian Pharma /
Statement of responsibility, etc Katherine Eban.
250 ## - EDITION STATEMENT
Edition statement First edition.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication New Delhi :
Name of publisher Juggernaut,
Year of publication 2019.
300 ## - PHYSICAL DESCRIPTION
Number of Pages xxviii, 482p.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
520 ## - SUMMARY, ETC.
Summary, etc In 2004, Dinesh Thakur, a senior employee of Ranbaxy, then India’s largest pharma company, discovered a terrible secret.Ranbaxy had been fabricating the test results of their drugs,endangering millions of patients. Thakur resigned and became a whistleblower to the US Food and Drug Administration, one of the regulators Ranbaxy had been lying to, and ultimately brought the multibillion-dollar behemoth to its knees. This is the sensational account of the high-stakes chase to bring Ranbaxy to book and the fall from grace of one of corporate India’s biggest success stories. But the rot in Indian pharma isn’t confined to Ranbaxy alone. In this book, investigative journalist Katherine Eban relies on over 20,000 FDA documents and interviews with over 240 people to show how fraud and trickery are deeply entrenched in much of the industry in India, and raises troubling questions about some of its biggest names – Wockhardt, Dr Reddy’s, Glenmark and RPG Life Sciences. Filled with shocking and eye-opening details, this book lays bare the ugly truth of Indian pharma. It will make you view every pill you take with foreboding and suspicion.
546 ## - LANGUAGE NOTE
Language note English.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Generic drugs
General subdivision Quality control.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Drug adulteration.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Source of acquisition Cost, normal purchase price Full call number Accession Number Cost, replacement price Price effective from Koha item type
        NASSDOC Library NASSDOC Library 2023-03-16 Overseas 0.00 615.1 EBA-B 52940 0.00 2023-05-25 Books